Pioneering perspectives in point-of-care manufacturing
Shaping the future of patient access to therapies
Point-of-care (PoC) cell manufacturing, a decentralized approach where cell therapies are produced locally at or near hospitals, presents a transformative opportunity to expand access to life-saving treatments.1 Unlike the traditional centralized model, where possible disadvantages such as logistical challenges, limited flexibility, and high costs might limit patient access to cell therapies, PoC cell manufacturing networks could streamline tailored therapy production to deliver therapies faster to patients.2
Listen to experiences from the field of how PoC cell manufacturing is overcoming barriers to bring care closer to patients, sign up to our clinical newsletter to stay up to date in the field, and make it realistic for you by exploring further information on PoC cell manufacturing for your indication of interest.
Revolutionizing brain cancer treatment: the promise of personalized immunotherapy
Prof. Misty Jenkins, Walter and Eliza Hall Institute (WEHI), Melbourne, Australia
Watch the interview (4:37 min)
Scaling cell therapy access: the impact of multi site manufacturing
Prof. Carlos Fernández de Larrea, Hospital Clinic Barcelona, Spain
Watch the interview (5:45 min)
Point-of-care manufacturing regulations: collaborative efforts for safe therapies
Prof. Chi Kong Li, MD, Pediatric hematology/oncology, Chinese University of Hong Kong
Watch the interview (5:38 min)
Racing against time – advancing cell therapies for brain cancer
David Reardon, MD, Dana-Farber Cancer Institute, USA
Watch the interview (5:24 min)
Stay connected with global PoC manufacturing and analytics experts
Sign up to our newsletter to keep up with the latest field developments and networking events
PoC manufacturing and analytics for your indication
Uncover our specific workflows that target your cells of interest:
You have previously chosen International as your location.
What do you want to do?